Achyut Healthcar
BSE: ACHYUT · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Achyut Healthcar's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Achyut Healthcare Limited is an Ahmedabad-based merchant exporter and trader specializing in pharmaceutical formulations and medical devices. The company sources products from third-party manufacturers to supply domestic and international markets, with a strategic focus on Africa and Southeast Asia.
Business Model
The company operates an asset-light business model by acting as a distributor and supply chain manager for pharmaceutical products. It relies on strategic partnerships with contract manufacturers rather than owning production facilities, focusing on the trading and export of generic medicines and surgical equipment.
- Incorporation Year:1996
- Listing Platform:BSE SME
Management Commentary
Management emphasizes the company's transition into the healthcare trading space to address the rising demand for affordable generic medicines. The firm is currently focused on scaling its distribution network and diversifying its product portfolio to strengthen its global market presence.
Growth Outlook
Growth is expected to be driven by the expansion of the company's product portfolio and the strengthening of its distribution network in emerging markets. The firm aims to leverage its lean operational structure to capitalize on the increasing global demand for affordable healthcare solutions.
Key Risks
- Supply Chain Dependency. The company relies entirely on third-party manufacturers, making it vulnerable to supply disruptions or quality control issues at partner facilities.
- Regulatory Risk. As an exporter of pharmaceutical products, the company is subject to stringent and varying regulatory requirements across multiple international jurisdictions.
- Currency Fluctuation. Exposure to international markets in Africa and Southeast Asia subjects the company to risks associated with foreign exchange volatility.
- Market Competition. The pharmaceutical trading sector is highly competitive, which may exert pressure on profit margins and market share.
Start your research today
Unlock AI insights, financials, peers and live data on Achyut Healthcar and 5,000+ companies — free.
Peers · Pharmaceuticals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Achyut HealthcarACHYUT | ₹168 Cr | — | — | — | 1.5% | — | — | +39.0% |
Albert DavidALBERTDAVD | ₹513 Cr | 22.73 | 13.48 | 11.4% | 11.0% | 5.8% | 7.5% | +12.1% |
Jenburkt Pharmaceuticals LimitedJENBURPH | ₹463 Cr | 13.31 | 8.46 | — | 32.0% | 17.6% | 23.2% | -4.3% |
Haleos Labs LimitedHALEOSLABS | ₹452 Cr | 28.60 | 12.72 | -3.1% | 13.6% | 7.4% | 10.3% | — |
TranschemTRANSCHEM | ₹424 Cr | 98.76 | 68.07 | -100.0% | 177.7% | 5.3% | 7.0% | +592.6% |
Medicamen BiotecMEDICAMEQ | ₹338 Cr | 33.59 | 15.53 | 24.7% | 11.3% | 4.1% | 6.2% | -27.9% |
As of Mar 2026
Financials
Achyut Healthcar
BSE: ACHYUT · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Achyut Healthcar's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Achyut Healthcare Limited is an Ahmedabad-based merchant exporter and trader specializing in pharmaceutical formulations and medical devices. The company sources products from third-party manufacturers to supply domestic and international markets, with a strategic focus on Africa and Southeast Asia.
Business Model
The company operates an asset-light business model by acting as a distributor and supply chain manager for pharmaceutical products. It relies on strategic partnerships with contract manufacturers rather than owning production facilities, focusing on the trading and export of generic medicines and surgical equipment.
- Incorporation Year:1996
- Listing Platform:BSE SME
Management Commentary
Management emphasizes the company's transition into the healthcare trading space to address the rising demand for affordable generic medicines. The firm is currently focused on scaling its distribution network and diversifying its product portfolio to strengthen its global market presence.
Growth Outlook
Growth is expected to be driven by the expansion of the company's product portfolio and the strengthening of its distribution network in emerging markets. The firm aims to leverage its lean operational structure to capitalize on the increasing global demand for affordable healthcare solutions.
Key Risks
- Supply Chain Dependency. The company relies entirely on third-party manufacturers, making it vulnerable to supply disruptions or quality control issues at partner facilities.
- Regulatory Risk. As an exporter of pharmaceutical products, the company is subject to stringent and varying regulatory requirements across multiple international jurisdictions.
- Currency Fluctuation. Exposure to international markets in Africa and Southeast Asia subjects the company to risks associated with foreign exchange volatility.
- Market Competition. The pharmaceutical trading sector is highly competitive, which may exert pressure on profit margins and market share.
Start your research today
Unlock AI insights, financials, peers and live data on Achyut Healthcar and 5,000+ companies — free.
Peers · Pharmaceuticals
As of Mar 2026